A resource of high-quality and versatile nanobodies for drug delivery
Zhuolun Shen(University of Pittsburgh), Yufei Xiang(University of Pittsburgh), Sandra Vergara(University of Pittsburgh), Apeng Chen(University of Pittsburgh), Zhengyun Xiao(University of Pittsburgh), Ulises Santiago(University of Pittsburgh), Changzhong Jin(University of Pittsburgh), Zhe Sang(University of Pittsburgh), Jiadi Luo(University of Pittsburgh), Kong Chen(University of Pittsburgh), Dina Schneidman‐Duhovny, Carlos J. Camacho(University of Pittsburgh), Guillermo Calero(University of Pittsburgh), Baoli Hu(University of Pittsburgh), Yi Shi(University of Pittsburgh)
Cited by 39Open Access
Abstract
-cytokine fusion constructs "Duraleukin" and demonstrated Duraleukin's high preclinical efficacy for cancer treatment in a melanoma model. This high-quality and versatile Nb toolkit will help tailor drug half-life to specific medical needs.
Related Papers
No related papers found
Powered by citation graph analysis